Deb S., NH
I’m an 8 1/2 year survivor of stage 4 lung cancer thanks to medical research, clinical trials, superb care at my cancer institute and pure luck! I have the EGFR and T7-90 mutations and first took erlotinib, a targeted therapy, for about 18 months. I’ve now been on osimertinib for 6 1/2 years, first through a clinical trial. I’ve been able to spend time with and make good memories with my son, visit old friends, become a birder, read so many good books and even traveled all over the continent for a year in my little blue jalopy! I’m happy that there’s ongoing research so I have some options when I start showing progression. I’m also especially interested in research on why so many women who have never smoked are getting lung cancer as well as expanding lung cancer screening to everyone.
Double Your Donation Today
This #GivingWeek, your donation means more than ever. Your support goes directly to our clean air and lung health initiatives, including ending COVID-19.
For a limited time every gift you make will be matched up to $100,000.
Thank you! You will now receive email updates from the American Lung Association.